- AVF Academy
- EAVLA Advanced Phlebology Webinar: May 2025
Foam sclerotherapy keeps earning a bigger role in venous care, from saphenous trunks to the veins beneath a leg ulcer, and retrievable filters still raise questions about long-term safety. In this Advanced Phlebology webinar, hosted by the Egyptian African Venous Lymphatic Association (EAVLA) with the American Venous Forum and the Journal of Vascular Surgery: Venous and Lymphatic Disorders, authors present new evidence and an international panel discusses how it applies to practice.
What you’ll learn
- How foam sclerotherapy holds up long term: in a multicenter study of 346 patients with primary chronic venous disease, ultrasound-guided foam sclerotherapy of the saphenous trunks achieved a 77.7 percent disease-free rate at five years, with most recurrences in trunks larger than 8 mm, while trunks 8 mm or smaller had recurrence rates similar to thermal and other nonthermal procedures
- Why the veins beneath a venous leg ulcer matter: the 2022 European Society for Vascular Surgery guidelines now recommend considering foam sclerotherapy of the sub-ulcer venous plexus, and one center’s approach uses 0.5 to 1 percent polidocanol foam, 5 to 10 mL per session for up to two sessions per limb, followed by compression bandaging
- What final multicenter results showed for the Gunther Tulip and Celect IVC filters: freedom from new symptomatic pulmonary embolism with a filter in place was 98.5 percent at 24 months, with no filter embolization or access site complications, and only one of 50 patients with strut perforation on imaging had related symptoms
- Perspectives from an international expert panel during discussion and audience Q&A
Agenda
- Welcome, Dr. Joseph Raffetto, 38th AVF President
- Final results of a prospective multicenter study of the Gunther Tulip and Celect IVC filters, Dr. John Kaufman
- Ultrasound-guided foam sclerotherapy of the saphenous trunks: five-year outcomes, Dr. Fabrizio Mariani
- Foam sclerotherapy of the sub-ulcer venous plexus for venous leg ulcers, Dr. Joseph Shalhoub
- Expert discussion and Q&A
Faculty
- Rashad Bishara (Host), President, EAVLA
- Joseph Raffetto, 38th AVF President
- John Kaufman, MD, MS
- Fabrizio Mariani
- Joseph Shalhoub, Imperial College London
- Tomasz Urbanek, MD, Professor and Vascular Surgeon, Medical University of Silesia, Katowice, Poland
- Windsor Ting, MD, Professor of Surgery, Icahn School of Medicine at Mount Sinai, New York
- Peter Pappas
- Alejandro Ochoa
- Suat Doganci
- Nehad A. Fouad
- Alvaro Orrego
Recorded live May 24, 2025.
Related
Dec 6, 2025
Learn when to use venoactive drugs such as micronized purified flavonoid fraction, why ablation length matters more than moda... more details Junctional Reflux, Ablation Outcomes, and Early TOTEM Trial Results: Advanc... Junctional Reflux, Ablation Outcomes, and Early TOTEM Trial Results: Advanced Phlebology Webinar
Nov 16, 2026
Learn how junctional reflux affects the success of endovenous ablation for great saphenous vein insufficiency and the first r... more details Oct 21, 2026
Learn when to operate on varicose veins after superficial vein thrombosis, based on real-world INSIGHTS-SVT data, and how pol... more details Oct 28, 2026
Learn how to diagnose, treat, and manage venous leg ulcers, from duplex ultrasound and intravascular ultrasound workup to abl... more details 


